Belfast
'We have seen improving momentum supported by a stronger order book and pipeline': Northern Ireland biotech firm reports £2.13million revenue as margins more than double
Belfast News LetterBelfast’s Fusion Antibodies posts a 9% increase in revenue and significant margin improvement, backed by platform development and new partnerships